TIGIT+ Tregs could activate its ligand CD155, and the activation of TIGIT/CD155 signaling was associated with the pathologic grade and lymph node metastasis of HNSCC. Here, TIGIT is linked to metastatic malignant neoplasm in the lymph nodes.